CorMedix Inc. Files Request with FDA for QIDP Designation for Neutrolin®

Neutrolin Label Expansion Approved in Germany

CorMedix Receives Approval from FDA to Initiate a Clinical Trial for Neutrolin in the US

CorMedix Announces FDA IND Filing for Neutrolin® in United States

Neutrolin Label Expansion Approved for the European Union

FDA Accepts CorMedix, Inc. Pivotal Phase 3 Study Protocol

CorMedix, Inc. Finalizes Pivotal Phase 3 Study Protocol for FDA

CorMedix Awarded European Patent for Neutrolin

CorMedix Inc. to Raise $2,000,000 in Follow on Offering